✦ LIBER ✦

Successful treatment of chronic-relapsing experimental autoimmune encephalomyelitis with linomide (LS-2616)

✍ Scribed by D.M. Karousis; U. Vourka-Karusis; R. Mizrachi-Koll; D. Lehmann; S. Slavin; O. Abramsky

Book ID: 119108106
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 84 KB
Volume: 35
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(91)91141-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of autoimmunity in

Successful treatment of autoimmunity in mrl/1 mice with ls-2616, a new immunomodulator

✍ A. Tarkowski; K. Gunnarsson; L.-Å. Nilsson; L. Lindholm; T. Stålhandske 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Successful treatment of established rela

Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody

✍ David J Miller; John J Bright; Subramaniam Sriram; Moses Rodriguez 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Treatment of Established Relapsing Exper

Treatment of Established Relapsing Experimental Autoimmune Encephalomyelitis with the Proteasome Inhibitor PS-5191

✍ Carol L Vanderlugt; Sandra M Rahbe; Peter J Elliott; Mauro C Dal Canto; Stephen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Treatment of chronic relapsing experimen

Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91–103 of myelin basic protein

✍ Xiao-min Su; Subramaniam Sriram 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 963 KB

Decreased CNS inflammation and absence o

Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis

✍ A.M. Al-Sabbagh; E.P. Goad; H.L. Weiner; P.A. Nelson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Murine chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) is a model of inflammatory demyelinating disease of the central nervous system (CNS) with similarity to multiple sclerosis (MS) in humans. Mice with confirmed neurologic deficits from CR-EAE were treated by oral administrati